Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/29796
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rad, J. S. | - |
dc.contributor.author | Yeskaliyeva, B. | - |
dc.contributor.author | Beyatlı, A. | - |
dc.contributor.author | Alfred, M. A. | - |
dc.contributor.author | Salehi, B. | - |
dc.contributor.author | Calina, D. | - |
dc.contributor.author | Docea, A. O. | - |
dc.contributor.author | İmran, M. | - |
dc.contributor.author | Kumar, N. V. A. | - |
dc.contributor.author | Roman, M. E. R. | - |
dc.contributor.author | Maroyi, A. | - |
dc.contributor.author | Martorell, M. | - |
dc.date.accessioned | 2022-12-12T06:39:48Z | - |
dc.date.available | 2022-12-12T06:39:48Z | - |
dc.date.issued | 2020-09-28 | - |
dc.identifier.citation | Rad, J. S. vd. (2020). "Pharmacological activities of psoralidin: A comprehensive review of the molecular mechanisms of action". Frontiers in Pharmacology, 11. | en_US |
dc.identifier.issn | 1663-9812 | - |
dc.identifier.uri | https://doi.org/10.3389/fphar.2020.571459 | - |
dc.identifier.uri | https://www.frontiersin.org/articles/10.3389/fphar.2020.571459/full | - |
dc.identifier.uri | http://hdl.handle.net/11452/29796 | - |
dc.description.abstract | Analysis of the most relevant studies on the pharmacological properties and molecular mechanisms of psoralidin, a bioactive compound from the seeds of Cullen corylifolium (L.) Medik. confirmed its complex therapeutic potential. In the last years, the interest of the scientific community regarding psoralidin increased, especially after the discovery of its benefits in estrogen-related diseases and as a chemopreventive agent. Growing preclinical pieces of evidence indicate that psoralidin has anticancer, antiosteoporotic, anti-inflammatory, anti-vitiligo, antibacterial, antiviral, and antidepressant-like effects. Here, we provide a comprehensive and critical review of psoralidin on its bioavailability, pharmacological activities with focus on molecular mechanisms and cell signaling pathways. In this review, we conducted literature research on the PubMed database using the following keywords: "Psoralidin" or "therapeutic effects" or "biological activity" or "Cullen corylifolium" in order to identify relevant studies regarding PSO bioavailability and mechanisms of therapeutic effects in different diseases based on preclinical, experimental studies. In the light of psoralidin beneficial actions for human health, this paper gathers complete information on its pharmacotherapeutic effects and opens new natural therapeutic perspectives in chronic diseases. | en_US |
dc.description.sponsorship | Comisión Nacional de Investigación Científica y Tecnológica | es |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Psoralea corylifolia | en_US |
dc.subject | Herbal medicine | en_US |
dc.subject | Psoralidin | en_US |
dc.subject | Bioavailability | en_US |
dc.subject | Biological properties | en_US |
dc.subject | Molecular mechanism | en_US |
dc.subject | Cell signalling pathways | en_US |
dc.subject | NF-Kappa B | en_US |
dc.subject | In-vivo | en_US |
dc.subject | Corylifolia | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Seeds | en_US |
dc.subject | Constituents | en_US |
dc.subject | Inhibition | en_US |
dc.subject | Cells | en_US |
dc.subject | Bioavailability | en_US |
dc.subject | Activation | en_US |
dc.title | Pharmacological activities of psoralidin: A comprehensive review of the molecular mechanisms of action | en_US |
dc.type | Review | en_US |
dc.identifier.wos | 000585940400001 | tr_TR |
dc.identifier.scopus | 2-s2.0-85095576565 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Bursa Uludağ Üniversitesi/Ziraat Fakültesi/Gıda Mühendisliği Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0003-3902-4360 | tr_TR |
dc.identifier.volume | 11 | tr_TR |
dc.relation.journal | Frontiers in Pharmacology | en_US |
dc.contributor.buuauthor | Kamiloğlu, Senem | - |
dc.contributor.researcherid | P-3633-2018 | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 33192514 | tr_TR |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 55754670700 | tr_TR |
dc.subject.scopus | Cullen Corylifolium; Angelicin; Bakuchiol | en_US |
dc.subject.emtree | Chitosan | en_US |
dc.subject.emtree | Coumestrol | en_US |
dc.subject.emtree | Eudragit | en_US |
dc.subject.emtree | Plant medicinal product | en_US |
dc.subject.emtree | Psoralidin | en_US |
dc.subject.emtree | Tetryzoline | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Acne vulgaris | en_US |
dc.subject.emtree | Antibacterial activity | en_US |
dc.subject.emtree | Antidepressant activity | en_US |
dc.subject.emtree | Antiapoptotic activity | en_US |
dc.subject.emtree | Antiinflammatory activity | en_US |
dc.subject.emtree | Antineoplastic activity | en_US |
dc.subject.emtree | Antioxidant activity | en_US |
dc.subject.emtree | Antiprotozoal activity | en_US |
dc.subject.emtree | Antiviral activity | en_US |
dc.subject.emtree | Cullen corylifolium | en_US |
dc.subject.emtree | Drug absorption | en_US |
dc.subject.emtree | Drug bioavailability | en_US |
dc.subject.emtree | Drug cytotoxicity | en_US |
dc.subject.emtree | Drug dosage form comparison | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Drug formulation | en_US |
dc.subject.emtree | Drug mechanism | en_US |
dc.subject.emtree | Drug megadose | en_US |
dc.subject.emtree | Drug potency | en_US |
dc.subject.emtree | Drug response | en_US |
dc.subject.emtree | Drug structure | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | IC50 | en_US |
dc.subject.emtree | Low drug dose | en_US |
dc.subject.emtree | Maximum plasma concentration | en_US |
dc.subject.emtree | Nanoencapsulation | en_US |
dc.subject.emtree | Neuroprotection | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Osteoporosis | en_US |
dc.subject.emtree | Pneumonia | en_US |
dc.subject.emtree | Psoriasis | en_US |
dc.subject.emtree | PUVA | en_US |
dc.subject.emtree | Review | en_US |
dc.subject.emtree | Signal transduction | en_US |
dc.subject.emtree | Suspension | en_US |
dc.subject.emtree | Systematic review | en_US |
dc.subject.emtree | Vasodilatation | en_US |
dc.subject.emtree | Vitiligo | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Kamiloglu_vd_2020.pdf | 1.06 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License